<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">NTN2 Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">Netrin-2</th></tr>
<tr><td class="label">Gene Symbol</td><td>NTN2</td></tr>
<tr><td class="label">Full Name</td><td>Netrin-2</td></tr>
<tr><td class="label">Chromosomal Location</td><td>19p13.3</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[4917](https://www.ncbi.nlm.nih.gov/gene/4917)</td></tr>
<tr><td class="label">OMIM</td><td>[601901](https://www.omim.org/entry/601901)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000121542](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000121542)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q8WWS8](https://www.uniprot.org/uniprot/Q8WWS8)</td></tr>
<tr><td class="label">Protein Family</td><td>Netrin</td></tr>
<tr><td class="label">Pathway</td><td>[Axon Guidance](/mechanisms/axon-guidance)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">NTN2 Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">Netrin-2</th></tr>
<tr><td class="label">Gene Symbol</td><td>NTN2</td></tr>
<tr><td class="label">Full Name</td><td>Netrin-2</td></tr>
<tr><td class="label">Chromosomal Location</td><td>19p13.3</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[4917](https://www.ncbi.nlm.nih.gov/gene/4917)</td></tr>
<tr><td class="label">OMIM</td><td>[601901](https://www.omim.org/entry/601901)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000121542](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000121542)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q8WWS8](https://www.uniprot.org/uniprot/Q8WWS8)</td></tr>
<tr><td class="label">Protein Family</td><td>Netrin</td></tr>
<tr><td class="label">Pathway</td><td>[Axon Guidance](/mechanisms/axon-guidance)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Netrin-2 (encoded by the NTN2 gene) is a secreted laminin-related protein that plays crucial roles in [axon guidance](/mechanisms/axon-guidance) during [neural development](/mechanisms/nervous-system-development). It belongs to the netrin family of axon guidance molecules, which are essential for the proper wiring of the [nervous system](/anatomy/nervous-system-overview)[@kennedy1994]. Netrin-2 is a bifunctional guidance cue, capable of both attracting and repelling growing axons depending on the receptor context[@livesey1997].
The netrin family includes several related proteins (netrin-1, netrin-3, netrin-4, and netrin-5) that share conserved domains responsible for receptor binding and guidance signaling. NTN2, while less studied than its paralog netrin-1, provides essential guidance functions during development and may have important roles in adult neural plasticity and repair[@moore2007].
Netrin proteins share a conserved structure consisting of:
Netrin-2 signals through two major receptor families:
The downstream effectors include:
During [neural development](/mechanisms/nervous-system-development), NTN2 expression follows specific spatiotemporal patterns:
In the adult brain, NTN2 expression is significantly lower than during development but is maintained at:
Netrin-2 has emerging roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis and potential therapy[@jiang2019]:
Synaptic dysfunction: The DCC/netrin signaling system regulates synaptic formation and maintenance. In AD, where synaptic loss correlates with cognitive decline, netrin-2 may play a protective role by supporting synaptic integrity[@xiong2015].
Axon guidance alterations: Amyloid-beta oligomers can disrupt netrin-2 signaling, potentially contributing to the axonal degeneration observed in AD brains.
Therapeutic potential: Exogenous netrin-1 (closely related to netrin-2) has been shown to:
In [Parkinson's disease](/diseases/parkinsons-disease), netrin-2 may have important neuroprotective effects[@wu2019]:
Dopaminergic neuron survival: The [substantia nigra](/brain-regions/substantia-nigra) pars compacta dopaminergic neurons are particularly vulnerable in PD. Netrin-2 signaling through DCC may support their survival and process outgrowth.
Axon guidance in basal ganglia: The [basal ganglia](/brain-regions/basal-ganglia) circuitry relies on precise axonal connections established during development and maintained through adulthood. Netrin-2 helps maintain these connections.
Regenerative potential: Studies suggest that enhancing netrin-2 expression could promote regeneration of dopaminergic axons in PD models.
Netrin-2 shows promise in stroke recovery[@lorenz2014]:
Axon regeneration: After ischemic injury, netrin-2 expression is upregulated in the penumbra region, and exogenous netrin-2 can promote axonal sprouting and functional recovery.
Angiogenesis: Netrin-2 also promotes blood vessel formation, supporting tissue repair post-stroke.
Neuroprotection: Netrin-2 has anti-apoptotic effects that can protect neurons in the ischemic core.
In spinal cord injury models, netrin-2 promotes regeneration[@han2014]:
Axon growth: Netrin-2 serves as a permissive substrate for regenerating axons across lesion sites.
Corticospinal tract: Specific enhancement of corticospinal axon regeneration has been observed with netrin-2 treatment.
Combination therapies: Netrin-2 works synergistically with other growth-promoting molecules for enhanced regeneration.
In [multiple sclerosis](/diseases/multiple-sclerosis), netrin-2 may play dual roles[@liu2014]:
Remyelination: Netrin-2 can promote oligodendrocyte precursor migration and differentiation.
Axonal protection: The guidance molecule may help maintain axonal integrity during demyelinating events.
Netrin-2 has shown promise in retinal disease models[@shan2015]:
Retinal ganglion cell survival: Netrin-2 protects retinal ganglion cells from death in glaucoma models.
Optic nerve regeneration: Following optic nerve injury, netrin-2 promotes axonal regeneration.
Netrin-2 and its receptors represent promising therapeutic targets:
Agonists: Recombinant netrin proteins or small molecule agonists could enhance neuronal survival and regeneration in various neurological conditions.
Receptor-specific compounds: Selective activators of DCC vs. UNC5 receptors could provide either regenerative or protective effects depending on the indication.
Gene therapy: Viral vector delivery of netrin-2 to specific brain regions has shown promise in preclinical models.
Studies of NTN2 utilize: